Why Passwords Are Still a Developer's Problem in 2026. The case against password-based authentication is well-established in the IAM community, but the practical implications for ...

Generate Biomedicines has filed for an IPO on the Nasdaq, seeking to raise upwards of $100 million for its AI-powered drug discovery operations. Incubated by Flagship Pioneering, Generate applies AI ...